Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | HFB301001 |
Synonyms | |
Therapy Description |
HFB301001 is an agonistic antibody targeting OX40, which potentially enhances effector T cells and decreases regulatory T cells, leading to antitumor activity (Ann Oncol 2022, Vol 33, Suppl 7, Abstract # S899). |